NEUMORA THERAPEUTICS INC (NMRA) Stock Analyst Ratings
NASDAQ:NMRA - Nasdaq - US6409791000 - Common Stock - Currency: USD
ChartMill assigns a Buy % Consensus number of 84% to NMRA. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 16.9. This target is 839.05% above the current price.
NMRA was analyzed by 15 analysts. The buy percentage consensus is at 84. So analysts seem to be very confident about NMRA.
In the previous month the buy percentage consensus was at a similar level.
NMRA was analyzed by 15 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-02-14 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-01-06 | B of A Securities | Maintains | Buy -> Buy |
| 2025-01-03 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-01-02 | Needham | Reiterate | Buy -> Buy |
| 2024-12-16 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-11-22 | RBC Capital | Reiterate | Outperform -> Outperform |
| 2024-11-13 | Needham | Reiterate | Buy -> Buy |
| 2024-11-13 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-11-05 | JP Morgan | Downgrade | Overweight -> Neutral |
| 2024-10-18 | Needham | Reiterate | Buy -> Buy |
| 2024-10-01 | HC Wainwright & Co. | Initiate | Buy |
| 2024-09-12 | Needham | Reiterate | Buy -> Buy |
| 2024-09-04 | RBC Capital | Reiterate | Outperform -> Outperform |
| 2024-08-07 | Needham | Reiterate | Buy -> Buy |
| 2024-07-22 | Needham | Initiate | Buy |
| 2024-07-08 | Mizuho | Initiate | Outperform |
| 2024-03-28 | RBC Capital | Reiterate | Outperform -> Outperform |
| 2024-03-18 | JP Morgan | Maintains | Overweight -> Overweight |
| 2024-03-08 | RBC Capital | Maintains | Outperform -> Outperform |
| 2023-11-08 | JP Morgan | Maintains | Overweight -> Overweight |
| 2023-10-10 | Guggenheim | Initiate | Buy |
| 2023-10-10 | William Blair | Initiate | Outperform |
| 2023-10-10 | RBC Capital | Initiate | Outperform |
| 2023-10-10 | Stifel | Initiate | Buy |
| 2023-10-10 | JP Morgan | Initiate | Overweight |
| 2023-10-10 | B of A Securities | Initiate | Buy |